Fundamentals-based quality & risk · not a recommendation
Raw blend 60 capped to 58 by a red flag.
Raw blend 60 → capped to 58
GICL scores 58/100 (Watch) on the Orion Score — moderate business quality (61), strong growth (71), moderate balance-sheet safety (51) and fair valuation (52). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
27/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Q3 FY2026
Revenue & Profit in ₹ Crores
| Quarter | Revenue | Net Profit | OPM | EPS |
|---|---|---|---|---|
| Q3 2026 | ₹47.31 | ₹6.92 | 21.4% | ₹0.42 |
| Q2 2026 | ₹37.57 | ₹1.72 | 9.2% | ₹0.16 |
| Q3 2025 | ₹38.31 | ₹1.53 | 6.8% | ₹0.31 |
| Q2 2025 | — | ₹0.45 | — | ₹0.04 |
Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2024 | ₹114.5 | ₹2.56 | ₹5.62 | 4.8% |
| FY 2023 | ₹113.68 | ₹1.92 | ₹5.09 | 4.3% |
| FY 2022 | ₹107.73 | ₹1.44 | ₹3.99 | 8.0% |
All values in ₹ Crores
| Metric | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Total Assets | ₹82.8 | ₹59.84 | ₹63.56 |
| Equity | ₹54.01 | ₹28.25 | ₹26.33 |
| Total Debt | ₹20.49 | ₹20.07 | ₹20.18 |
| Cash | ₹0.96 | ₹0.54 | ₹1.38 |
| Net Debt | ₹19.53 | ₹19.54 | ₹18.81 |
| Working Capital | ₹43.01 | ₹26.41 | ₹24.01 |
Q3 FY2026
Quarter-over-Quarter Trend
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Q3 FY2026 | 63.49% | — | 0.01% ↑ | 36.5% |
| Q2 FY2026 | 63.49% ↑ | — | 0% | 36.51% ↓ |
| Q1 FY2026 | 58.99% ↑ | — | 0% | 41.01% ↓ |
| Q4 FY2025 | 58.68% ↑ | — | 0% | 41.32% ↓ |
| Q2 FY2025 | 58.15% ↓ | — | 0% | 41.85% ↑ |
| Q4 FY2024 | 70.79% | — | 0% | 29.21% |
| Q2 FY2024 | 70.79% ↓ | — | 0% | 29.21% ↑ |
| Q4 FY2023 | 74.18% | — | 0% | 25.82% |
No recent corporate actions
Ask: "Is GICL stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.